Molecular Genetics of Follicular-Derived Thyroid Cancer

被引:35
作者
Macerola, Elisabetta [1 ]
Poma, Anello Marcello [1 ]
Vignali, Paola [1 ]
Basolo, Alessio [2 ]
Ugolini, Clara [1 ]
Torregrossa, Liborio [1 ]
Santini, Ferruccio [2 ]
Basolo, Fulvio [1 ]
机构
[1] Univ Pisa, Dept Surg Med Mol Pathol & Crit Area, Via Savi 10, I-56126 Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Via Savi 10, I-56126 Pisa, Italy
关键词
molecular genetics; molecular pathology; thyroid cancer; papillary thyroid cancer; TERT PROMOTER MUTATIONS; NUCLEAR FEATURES NIFTP; BRAF; TUMORS; LAROTRECTINIB; PATHOGENESIS; ASSOCIATION; MANAGEMENT; INHIBITORS; LANDSCAPE;
D O I
10.3390/cancers13051139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Thyroid tumors that derive from follicular cells are not a homogeneous entity, showing variable morphological appearance and different degrees of differentiation. Molecular markers are useful for both diagnostic purposes and prognostic stratification of patients. In presurgical setting, molecular testing of indeterminate thyroid nodules on aspirates provides useful diagnostic information; the molecular analysis on tumor tissues can also reveal the presence of genetic alterations related to patients' prognosis. In recent years, the molecular characterization of these tumors has acquired even more importance thanks to the introduction of targeted drugs. This review summarizes the current literature on the molecular landscape of follicular-derived thyroid tumors. Thyroid cancer is the most common type of endocrine-related malignancy, whose incidence rates have increased dramatically in the last few decades. Neoplasms of follicular origin generally have excellent prognosis, with the exception of less differentiated tumors. Follicular-derived thyroid cancer can manifest as a variety of morphologically distinct entities, characterized by various degrees of differentiation and invasiveness. Histological evaluation is thus crucial for the definition of patients' prognosis. However, within each histological subtype, tumor behavior can be highly variable, and, in this respect, molecular characterization can provide insightful information to refine the risk stratification of tumors. In addition to the importance of its prognostic role, molecular testing can be used to support the differential diagnosis of thyroid nodules in the absence of marked cyto-morphological aberrations. Finally, with the advent of targeted drugs, the presence of molecular alterations will guide the therapeutic strategies for patients with advanced tumors who do not respond to standard treatment. This review aims to describe the genetic landscape of follicular-derived thyroid tumors also highlighting differences across histological subtypes.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [21] The Prognostic Implications from Molecular Testing of Thyroid Cancer
    Ozgursoy, Ozan B.
    Eisele, David W.
    Tufano, Ralph P.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2014, 47 (04) : 595 - +
  • [22] Molecular Genetics of Diffuse Sclerosing Papillary Thyroid Cancer
    Alswailem, Meshael
    Alghamdi, Balgees
    Alotaibi, Anwar
    Aljomiah, Abeer
    Al-Hindi, Hindi
    Murugan, Avaniyapuram Kannan
    Abouelhoda, Mohamed
    Shi, Yufei
    Alzahrani, Ali S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (09) : E704 - E711
  • [23] Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
    Park, Hyunju
    Shin, Hyeong Chan
    Yang, Heera
    Heo, Jung
    Ki, Chang-Seok
    Kim, Hye Seung
    Kim, Jung-Han
    Hahn, Soo Yeon
    Chung, Yun Jae
    Kim, Sun Wook
    Chung, Jae Hoon
    Oh, Young Lyun
    Kim, Tae Hyuk
    MODERN PATHOLOGY, 2022, 35 (02) : 186 - 192
  • [24] Editorial: Clinical and Molecular Epidemiology of Thyroid Cancer of Follicular Origin
    Malaguarnera, Roberta
    Vella, Veronica
    Pellegriti, Gabriella
    Belfiore, Antonino
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [25] Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network
    Giordano, Thomas J.
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (01) : 1 - 4
  • [26] Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions
    Handkiewicz-Junak, Dada
    Czarniecka, Agnieszka
    Jarzab, Barbara
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 322 (1-2) : 8 - 28
  • [27] Genetics of medullary thyroid cancer: An overview
    Accardo, Giacomo
    Conzo, Giovanni
    Esposito, Daniela
    Gambardella, Claudio
    Mazzella, Marco
    Castaldo, Filomena
    Di Donna, Carlo
    Polistena, Andrea
    Avenia, Nicola
    Colantuoni, Vittorio
    Giugliano, Dario
    Pasquali, Daniela
    INTERNATIONAL JOURNAL OF SURGERY, 2017, 41 : S2 - S6
  • [28] Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis
    Nikiforova, Marina N.
    Nikiforov, Yuri E.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2008, 8 (01) : 83 - 95
  • [29] Genetics of thyroid nodules and thyroid carcinoma
    Fuehrer, D.
    INTERNIST, 2018, 59 (07): : 674 - 680
  • [30] Molecular Markers in the Diagnosis of Thyroid Cancer in Indeterminate Thyroid Nodules
    Kannan, Subramanian
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2022, 13 (01) : 11 - 16